MusclePharm Corporation: 10-Q filed 2014-11-14
What MusclePharm Corporation reported in its quarterly report filed 2014-11-14 (fiscal Q3 2014): 42 published measures, 111 facts as tagged in accession 0001564590-14-005822.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-11-14
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001564590-14-005822 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MusclePharm Corporation filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 79,610,086 | USD | |
| At 2013-12-31 | 52,157,696 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 41,520,925 | USD | |
| At 2013-12-31 | 32,423,160 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 38,089,161 | USD | |
| At 2013-12-31 | 19,734,536 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 602,618 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,404,338 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -3,945,836 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -13,729,627 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 3,735,411 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 825,164 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | -79,423,079 | USD | |
| At 2013-12-31 | -81,827,417 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 11,032,996 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 10,652,781 | shares | 273 |
| 2013-07-01 to 2013-09-30 | 8,475,084 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 6,626,125 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 12,612,896 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 12,112,017 | shares | 273 |
| 2013-07-01 to 2013-09-30 | 8,475,084 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 6,626,125 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 0.05 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 0.23 | USD/shares | 273 |
| 2013-07-01 to 2013-09-30 | -0.47 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -2.07 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 0.05 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 0.2 | USD/shares | 273 |
| 2013-07-01 to 2013-09-30 | -0.47 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -2.07 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 94,545 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 171,492 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 7,303,012 | USD | |
| At 2013-12-31 | 2,613,584 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 6,942,357 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 1,588,067 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -4,537,455 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -2,976,893 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -4,872,780 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -8,335,192 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 59,027,678 | USD | |
| At 2013-12-31 | 44,526,480 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 41,385,236 | USD | |
| At 2013-12-31 | 32,368,521 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 28,096,948 | USD | |
| At 2013-12-31 | 26,048,483 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 6,866,064 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 23,220,072 | USD | |
| At 2013-12-31 | 13,741,180 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 1,362,881 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 103,537 | USD | 273 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 19,494,145 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 51,453,415 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 12,278,980 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 31,819,494 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 24,027,143 | USD | |
| At 2013-12-31 | 15,772,368 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 14,956,690 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 48,476,522 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 7,406,200 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 23,484,302 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 3,651,739 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 7,881,047 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,936,610 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,000,831 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 735,472 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,996,301 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 181,908 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 441,269 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 10,996,221 | shares | |
| At 2013-12-31 | 9,089,490 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 125,014,545 | USD | |
| At 2013-12-31 | 103,064,901 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | -32,392 | USD | |
| At 2013-12-31 | -14,042 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 8,045,600 | USD | |
| At 2013-12-31 | 2,562,502 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 9,569,996 | USD | |
| At 2013-12-31 | 3,974,575 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 2,266,984 | USD | |
| At 2013-12-31 | 1,360,991 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 6,866,064 | USD | |
| At 2013-12-31 | 155,165 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 270,582 | USD | |
| At 2013-12-31 | 144,229 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 4,894,350 | USD | |
| At 2013-12-31 | 2,317,901 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 697,163 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,575,830 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -3,945,836 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -13,729,627 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 565,561 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,385,989 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -3,900,425 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -13,678,139 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 950,166 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 510,890 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -156,194 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 422,102 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 0 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 5,234,618 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 5,552,723 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 926,944 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -5,394,435 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 9,148,133 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 7,767,673 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 7,424,271 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 9,375,189 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 2,039,228 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 14,652,512 | USD | 273 |
Inspect the source
- Entity
- MusclePharm Corporation / CIK 0001415684
- Captured
- SEC response SHA-256
468a04d5e93b916c24c9590128d034d873e433232d8fd2a3bf40cb8a957ad42c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001415684.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))